Rated 5.00 out of 5 based on 1 customer rating
(1 customer review)

Ipamorelin (5Mg)

$39.95

Availability: 6 in stock

Research-Grade | 99%+ Purity | Third-Party Tested

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist a synthetic pentapeptide designed to stimulate growth hormone release through a mechanism distinct from growth hormone-releasing hormone (GHRH) pathways. Its high selectivity for the GHS-R1a receptor, combined with minimal influence on cortisol, prolactin, and ACTH levels, makes it one of the cleanest and most research-specific growth hormone secretagogues available.

Ipamorelin (5Mg)

SKU ipamorelin Category

This selectivity is what distinguishes ipamorelin as a particularly valuable research compound. Unlike broader secretagogues, its targeted receptor profile allows investigators to study growth hormone secretion dynamics in relative isolation without the confounding hormonal variables that complicate interpretation of less selective compounds. This precision makes it especially relevant for laboratories requiring clean, reproducible growth hormone stimulation data.

Research applications include growth hormone secretion pattern studies, ghrelin receptor signaling investigations, body composition and lean tissue metabolism research, bone density and skeletal integrity studies, and sleep-associated growth hormone pulse analysis. Its well-documented selectivity profile and extensive preclinical literature make ipamorelin a foundational compound in endocrinological and metabolic research settings.

Every vial is HPLC-validated and supplied with third-party COA documentation confirming 99%+ purity and structural integrity.

Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: 711.85 g/mol
Storage: Lyophilized at −20°C | Reconstitute under sterile conditions

FOR RESEARCH USE ONLY

1 review for Ipamorelin (5Mg)

  1. Rated 5 out of 5

    Admin

    Clear labeling, professional presentation, and straightforward research specifications. The product information was easy to review and matched the laboratory-focused approach of the site

Add a review

Your email address will not be published. Required fields are marked *

COAS

PRODUCT BATCH TESTING ORDERED SAMPLE RECEIVED STATUS ACTION
BPC157 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
IGF-1 LR3 1mg 020 2 APRIL 2026 13 APRIL 2026 CURRENT View COA
PT-141 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Retatrutide 20mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 10mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Semiglutide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
TB-500 021 2 FEB 2026 13 FEB 2026 CURRENT View COA
Tesamorelin 10mg 021 1 JULY 2025 7 JULY 2025 CURRENT View COA
Tirzepatide 30mg 020 2 MAY 2026 13 MAY 2026 CURRENT View COA
Scroll to Top